Relation of ABO blood groups to the severity of coronary atherosclerosis: An Gensini score assessment

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 748-753

  Gong, Ping ^a,b   Luo, Song Hui ^b   Li, Xiao Lin ^a   Guo, Yuan Lin ^a   Zhu, Cheng Gang ^a   Xu, Rui Xia ^a   Li, Sha ^a   Dong, Qian ^a   Liu, Geng ^a   Chen, Juan ^a   Zeng, Rui Xiang ^a   Li, Jian Jun ^a  

^a FUWAI HOSPITAL   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

ABO blood group; Coronary atherosclerosis; Gensini score; Risk factor

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR RISK; CHINESE; CLINICAL ASSESSMENT; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

EID: 84910657649     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.107     Document Type: Article

References (28)

1. Erikssen J., Thaulow E., Stormorken H., et al. ABO blood groups and coronary heart disease (CHD). A study in subjects with severe and latent CHD. Thromb. Haemost. 1980, 43:137-140.
2. Carpeggiani C., Coceani M., Landi P., et al. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010, 211:461-466.
3. Garrison R.J., Havlik R.J., Harris R.B., et al. ABO blood group and cardiovascular disease: the Framingham study. Atherosclerosis 1976, 25:311-318.
4. Whincup P.H., Cook D.G., Phillips A.N., et al. ABO blood group and ischaemic heart disease in British men. Br. Med. J 1990, 300:1679-1682.
5. Deloukas P., Kanoni S., Willenborg C., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 2013, 45:25-33.
6. Silbernagel G., Chapman M.J., Genser B., et al. High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis. J.Am. Coll. Cardiol. 2013, 62:291-299.
7. Wu O., Bayoumi N., Vickers M.A., et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J.Thromb. Haemost. 2008, 6:62-69.
8. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998, 38:975-988.
9. Karabuva S., Carevic V., Radic M., et al. The association of ABO blood groups with extent of coronary atherosclerosis in croatian patients suffering from chronic coronary artery disease. Biochem. Med. (Zagreb) 2013, 23:351-359.
10. Kaya A., Tanboga I.H., Kurt M., et al. Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyol. Derg. 2014, 14:55-60.
11. Gisbert J.P., Gomollon F. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am. J. Gastroenterol. 2008, 103:1783-1800.
12. Park M.S., Kim D.H., Park S.J., et al. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance. Dig. Dis. Sci. 2014 Sep 20, [Epub ahead of print].
13. Gensini G.G. Amore meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 1983, 51:606.
14. Sinning C., Lillpopp L., Appelbaum S., et al. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin. Res. Cardiol. 2013, 102:495-503.
15. Anvari M.S., Boroumand M.A., Shoar S., et al. Ascending aorta aneurysm and blood group A among Iranian patients. Thromb. Res. 2013, 131:e51-53.
16. Ohira T., Cushman M., Tsai M.Y., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). J.Thromb. Haemost. 2007, 5:1455-1461.
17. Nydegger U.E., Wuillemin W.A., Julmy F., et al. Association of ABO histo-blood group B allele with myocardial infarction. Eur. J. Immunogenet 2003, 30:201-206.
18. von Beckerath N., Koch W., Mehilli J., et al. ABO locus O1 allele and risk of myocardial infarction. Blood Coagul. Fibrinolysis 2004, 15:61-67.
19. Lee H.F., Lin Y.C., Lin C.P., et al. Association of blood group A with coronary artery disease in young adults in Taiwan. Intern Med. 2012, 51:1815-1820.
20. He M., Wolpin B., Rexrode K., et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2314-2320.
21. Wauters E., Carruthers K.F., Buysschaert I., et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE genetics Study. Eur. Heart J. 2013, 34:993-1001.
22. Chen Y., Chen C., Ke X., et al. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ. Cardiovasc Genet. 2014, 7:43-48.
23. Jenkins P.V., O'Donnell J.S. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?. Transfusion 2006, 46:1836-1844.
24. O'Donnell J., Laffan M.A. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus. Med. 2001, 11:343-351.
25. Ray K.K., Francis S., Crossman D.C. Measurement of plasma von Willebrand factor in acute coronary syndromes and the influence of ABO blood group status. J.Thromb. Haemost. 2004, 2:2053-2054.
26. Paterson A.D., Lopes-Virella M.F., Waggott D., et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1958-1967.
27. Barbalic M., Dupuis J., Dehghan A., et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum. Mol. Genet. 2010, 19:1863-1872.
28. Teng M.S., Hsu L.A., Wu S., et al. Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis 2013, 228:406-412.